Journal of Clinical Lipidology

Journal

Publication Venue For

  • Factors associated with time to initiation of a PCSK9 inhibitor after hospital discharge for acute myocardial infarction.  16:75-82. 2022
  • Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group.  15:629-648. 2021
  • Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction.  15:665-673. 2021
  • One-year statin persistence and adherence in adults with HIV in the United States.  15:181-191. 2021
  • Intermittent chylomicronemia caused by intermittent GPIHBP1 autoantibodies.  14:197-200. 2020
  • Residual risk for coronary heart disease events and mortality despite intensive medical management after myocardial infarction.  14:260-270. 2020
  • JCL roundtable: Omega-3 fatty acids and cardiovascular outcomes.  14:4-15. 2020
  • Dyslipidemia is associated with pediatric nonalcoholic fatty liver disease.  12:981-987. 2018
  • Low-density lipoprotein cholesterol response after statin initiation among persons living with human immunodeficiency virus.  12:988-998.e5. 2018
  • PCSK9 inhibitors for prevention of atherosclerotic cardiovascular disease.  12:835-843. 2018
  • Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial.  12:348-355.e2. 2018
  • Metabolic syndrome cluster does not provide incremental prognostic information in patients with stable cardiovascular disease: A post hoc analysis of the AIM-HIGH trial.  11:1201-1211. 2017
  • Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysis.  11:972-985.e9. 2017
  • Extreme hypertriglyceridemia, pseudohyponatremia, and pseudoacidosis in a neonate with lipoprotein lipase deficiency due to segmental uniparental disomy.  11:757-762. 2017
  • Hydrophilic vs lipophilic statins in coronary artery disease: A meta-analysis of randomized controlled trials.  11:624-637. 2017
  • Body mass index and glycemic control influence lipoproteins in children with type 1 diabetes.  10:1240-1247. 2016
  • An assessment by the Statin cognitive safety task force: 2014 update.  8. 2014
  • Discordance between high non-HDL cholesterol and high LDL-cholesterol among US adults.  8:86-93. 2014
  • JCL Roundtable: Lipid-lowering drugs in those older than 75 years of age.  8:533-541. 2014
  • Lipoprotein (a): Perspectives from a lipid-referral program.  6:66-73. 2012
  • Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists.  5:338-367. 2011
  • Assessing and addressing risk of cardiovascular disease in perimenopausal and early postmenopausal women.  4:324-334. 2010
  • Management of stable patients with coronary heart disease: Clinical implications of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.  1:564-574. 2007
  • Peptide mimetics of apolipoproteins improve HDL function.  1:142-147. 2007

    • International Standard Serial Number (issn)

  • 1933-2874

    • Electronic International Standard Serial Number (eissn)

  • 1876-4789